Full-Time

Senior Account Manager

Industry

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

No salary listed

Bengaluru, Karnataka, India

In Person

PhD

Category
Sales & Account Management
Required Skills
Salesforce

Get referred to Cell Signaling Technology

See people who can refer or advise you

Requirements
  • Ph.D. Life Sciences or a related field.
  • 7-10+ years of experience in life science sales, preferably in pharma, biotech, or CRO/CDMO markets with antibody-based solutions with a proven track record of managing complex key accounts.
  • Practical experience with common antibody applications (e.g., IHC, Flow Cytometry, ELISAs, High Content Imaging).
  • Strong functional understanding of research and development, drug discovery and diagnostic workflows.
  • Proven ability to manage complex sales environments and build long-term customer relationships.
  • Excellent communication, presentation, and time management skills.
  • Computer proficiency including Microsoft Office and CRM systems like Salesforce.com.
  • Ability to travel regularly within the assigned territory, with occasional domestic/international travel.
  • Located within the Greater Bangalore Area.
Responsibilities
  • Drive revenue growth by promoting, negotiating, and strategically positioning CST’s full range of antibody products, services, and scientific solutions across assigned accounts.
  • Maintain and expand business within national and global key accounts, focusing on solution-based, consultative selling and long-term account development.
  • Develop and execute comprehensive account plans aligned with CST’s business objectives, including identifying high-potential accounts, mapping organizational stakeholders, and implementing tailored engagement strategies to maximize account penetration.
  • Accurately forecast sales performance monthly, monitor pipeline health, and track/report key activities and outcomes in CRM systems (e.g., Salesforce), ensuring data-driven decision-making.
  • Optimize account coverage and resource allocation by prioritizing high-value accounts, planning regular on-site visits, and leveraging digital engagement strategies to strengthen relationships.
  • Identify opportunities for cross-selling and upselling, introducing complementary products and services to deepen account penetration and strengthen long-term partnerships.
  • Collaborate with internal teams to develop tailored proposals, pricing strategies, and contract negotiations that align with customer needs and company objectives.
  • Cultivate and sustain strategic relationships with key researchers, KOLs, opinion leaders, and decision-makers across R&D, purchasing, legal, and finance functions.
  • Establish collaborative partnerships with shared resource facilities, core labs, and scientific teams to identify opportunities for research collaborations, product adoption, and joint scientific initiatives.
  • Serve as a trusted advisor to customers, providing insights, scientific guidance, and proactive solutions to address current and emerging challenges.
  • Deliver exceptional customer experience by anticipating needs, responding promptly to inquiries, and ensuring consistent, high-quality engagement across all touch points
  • Partner with internal technical experts to provide scientific demonstrations, training, and troubleshooting, ensuring customers derive maximum value from CST products and services.
  • Collaborate with Sales, Product Management, Marketing, R&D, Legal, Finance, and international teams to execute strategic account initiatives and deliver high-impact customer engagement.
  • Serve as a voice of the customer, providing timely and actionable feedback to support product development, service improvement, and commercialization strategies.
  • Coordinate with technical/application scientists to develop customized scientific solutions, troubleshoot challenges, and ensure seamless execution of collaborative projects.
  • Act as a bridge between global and regional teams to ensure alignment on account strategy, key messaging, and deliverables.
  • Continuously gather and analyze market intelligence, including customer trends, competitor activity, and emerging scientific needs, and communicate insights to internal stakeholders to influence strategy.
  • Identify and evaluate new business opportunities, including emerging scientific areas, unmet research needs, or adjacent market segments, to expand CST’s footprint.
  • Represent CST at scientific conferences, symposia, and customer meetings, building relationships, monitoring industry developments, and positioning the company as a thought leader.
  • Provide input on strategic planning and portfolio development, ensuring account strategies align with long-term company goals.
  • Maintain accurate account records, pricing agreements, and contract documentation to ensure data integrity and organizational compliance.
  • Ensure all activities comply with ethical sales practices, contractual obligations, purchasing regulations, and internal policies.
  • Manage expense budgets and reporting, ensuring timely submission of travel, meeting, and project costs.
  • Track and report account metrics, performance indicators, and progress toward strategic objectives, supporting management decision-making.
Desired Qualifications
  • Doctorate degree in Biology or related field.
  • Experience selling to both commercial biopharma / Industry and academic/government accounts with particular emphasis on Industry accounts.
  • Deep rooted experience with drug development.
  • Familiarity with strategic selling methodologies and scientific collaborations.
  • Demonstrated success in high-value solution and services selling.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
  • CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
  • Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.

What critics are saying

  • CST sells research-use-only reagents; a single validation miss destroys trust fast.
  • Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
  • If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.

What makes Cell Signaling Technology unique

  • CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
  • CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
  • CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.